Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06298721 · ClinicalTrials.gov registry record · NA

Improving Total Knee Arthroplasty Dissatisfaction Through a Personalized Approach Focusing on PROMs Phenotypes

A NA study of Surgery and Knee Osteoarthritis, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06298721: Recruiting NA study of Surgery and Knee Osteoarthritis, sponsored by The Cleveland Clinic.

NCT06298721 is a NA study of Surgery and Knee Osteoarthritis that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 300 participants, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06298721, a NA study of Surgery and Knee Osteoarthritis, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlled trial to assess whether the implementation of a TKA Personalized Outcome Prediction Tool to set expectation, in addition to targeted interventions to address patients with poor baseline mental health and poor physical function, improves satisfaction at 1-year (when compared to standard of care).

Primary Outcome

Patient Acceptable Symptom State (PASS) anchoring question of: "Taking into account all the activity you have during your daily life, your level of pain and also your activity limitations and participation restrictions, do you consider the current state of your knee satisfactory?" to measure satisfaction

Interventions

  • BEHAVIORAL Personalized outcome prediction tool + targeted interventions
  • BEHAVIORAL Standard of Care TKA

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-03-12
Est. Completion 2027-03
Phase NA
The Cleveland Clinic

688 total trials

What NCT06298721 shows while recruiting

NCT06298721 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Personalized outcome prediction tool + targeted interventions is the first listed.

NCT06298721 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06298721 about?

NCT06298721 is a clinical study titled "Improving Total Knee Arthroplasty Dissatisfaction Through a Personalized Approach Focusing on PROMs Phenotypes". This study is a randomized controlled trial to assess whether the implementation of a TKA Personalized Outcome Prediction Tool to set expectation, in addition to targeted interventions to address patients with poor baseline mental health and poor physical function, improves satisfaction at 1-year (w...

What is the current status of trial NCT06298721?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-03-12. Estimated completion is 2027-03.

What conditions does trial NCT06298721 study?

This clinical trial studies the following conditions: Surgery, Knee Osteoarthritis, Knee Arthropathy.

What interventions are being tested in trial NCT06298721?

The interventions under investigation include: Personalized outcome prediction tool + targeted interventions (BEHAVIORAL), Standard of Care TKA (BEHAVIORAL).

Who is sponsoring clinical trial NCT06298721?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06298721 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06298721's enrollment target sits among peer trials

300 31st of 120 higher than 89 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06298721, the US trial registry maintained by the National Library of Medicine. NCT06298721 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.